Thursday, October 29, 2026

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

K-Food Expansion: How Korean Restaurants Are Conquering the U.S. Market

South Korean food brands expand globally, pivoting from China to the US, with strong growth in Japan and Vietnam despite challenges.

Breakthrough in MASH Treatment: How miRNA-10a Outperforms Resmetirom in Fat Reduction

RXBio's miRNA-10a shows superior efficacy over Resmetirom in treating MASH, reducing fat, fibrosis, and inflammation significantly.

Hye Ji Kim

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.